TerminatedNCT02176824
Official study titleAdjunct Total Sleep Deprivation, Sleep Phase Advance, and White Light Therapy Vs. Partial Sleep Deprivation, Sleep Phase Delay, and Amber Light Therapy as Adjunctive Treatments in Acutely Suicidal and Depressed Inpatients.
This study ended early.
In CharlestonDepression, Suicidality, ...Behavioural studyAges 18–90
- Countries
- United States
- Sponsor
- Medical University of South Carolina
CompletedNCT04939818
Official study titleA Study to Investigate the Feasibility of Administration of a Speech Battery and the Use of Speech-based Biomarkers for the Clinical Assessment of Common Neurodegenerative and Psychiatric Disorders in a Remote Setting.
This study has finished and is no longer accepting participants.
In LondonDepression, BipolarityObservational studyAges 18–85
- Countries
- United Kingdom
- Sponsor
- Novoic Limited
CompletedNCT04828226
Official study titleClonidine to Prevent Postictal Delirium After ElectroConvulsive Therapy: a Randomised, Placebo-controlled, Triple-blind, Single-centre Trial.
This study has finished and is no longer accepting participants.
In BernDepression, BipolarityMedication studyAges 18+
- Countries
- Switzerland
- Sponsor
- Insel Gruppe AG, University Hospital Bern
CompletedNCT02860910
Official study titleCross-Cultural Cognitive Behavioral Group Therapy: Evaluating the Effectiveness of a Manualized Cognitive Behavior Group Therapy Treatment for the Management of Menopause Symptoms in a Mood and Anxiety Disorder Population
This study has finished and is no longer accepting participants.
In ClevelandDepression, BipolarityBehavioural studyAges 40–65
- Countries
- United States
- Sponsor
- Danette Conklin, PhD
CompletedNCT02423824
Official study titleExploring the Neural Substrates of Cognitive Dysfunction With Glucagon-like Peptide-1 Agonists
This study has finished and is no longer accepting participants.
In TorontoDepression, BipolarityInterventional studyAges 18–45
- Countries
- Canada
- Sponsor
- University Health Network, Toronto
CompletedNCT06661616
Official study titleCognitive Effects Associated With Hippocampal Neurogenesis Induced by Electroconvulsive Therapy in the Treatment of Depression
This study has finished and is no longer accepting participants.
In ParisDepression, BipolarityObservational studyAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier St Anne
CompletedNCT02256566
This study has finished and is no longer accepting participants.
In New YorkDepression, Anxiety, ...Behavioural studyAges 18–80
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
CompletedNCT00829400
This study has finished and is no longer accepting participants.
In West HavenPTSD, Schizophrenia, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- VA Connecticut Healthcare System
CompletedNCT00895258
This study has finished and is no longer accepting participants.
In San DiegoSchizophrenia, Bipolarity, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of California, San Diego
CompletedNCT05380583
Official study titleTreatment Engagement in Families With Substance Use and Psychosis: A Pilot Study
This study has finished and is no longer accepting participants.
In BelmontAddiction, Schizophrenia, ...Behavioural studyAges 18–70
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
CompletedNCT02421965
Official study titleComparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness: Patient Engagement, Satisfaction, and Outcomes
This study has finished and is no longer accepting participants.
In ChicagoSchizophrenia, Depression, ...Behavioural studyAges 18+
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
CompletedNCT00303602
Official study titleBMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)
This study has finished and is no longer accepting participants.
Multiple locations, including EscondidoSchizophrenia, BipolarityMedication studyAges 18–65
- Countries
- United States, Canada, Mexico, + 1 other
- Sponsor
- Eli Lilly and Company